Search Results - "Schlifke, Irene"
-
1
Seizure Suppression by GDNF Gene Therapy in Animal Models of Epilepsy
Published in Molecular therapy (01-06-2007)“…Temporal lobe epilepsy patients remain refractory to available anti-epileptic drugs in 30% of cases, indicating a need for novel therapeutic strategies. In…”
Get full text
Journal Article -
2
Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures
Published in Brain (London, England : 1878) (01-09-2010)“…Gene therapy using recombinant adeno-associated viral vectors overexpressing neuropeptide Y in the hippocampus exerts seizure-suppressant effects in rodent…”
Get full text
Journal Article -
3
VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures
Published in PloS one (12-07-2012)“…Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and…”
Get full text
Journal Article -
4
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning
Published in Hippocampus (01-01-2008)“…Recombinant adeno‐associated viral (rAAV) vector‐induced neuropeptide Y (NPY) overexpression in the hippocampus exerts powerful antiepileptic and…”
Get full text
Journal Article -
5
Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP
Published in Experimental neurology (01-02-2009)“…Recently, hippocampal neuropeptide Y ( NPY) gene therapy has been shown to effectively suppress both acute and chronic seizures in animal model of epilepsy,…”
Get full text
Journal Article -
6
GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus
Published in Experimental neurology (01-04-2009)“…To date, a variety of pharmacological treatments exists for patients suffering epilepsy, but systemically administered drugs offer only symptomatic relief and…”
Get full text
Journal Article -
7
Brain area, age and viral vector-specific glial cell-line-derived neurotrophic factor expression and transport in rat
Published in Neuroreport (11-06-2007)“…We investigated the feasibility of viral vector-mediated expression and axonal transport of the glial cell-line-derived neurotrophic factor, a potential…”
Get full text
Journal Article -
8
Making the patient voice heard in a research consortium: experiences from an EU project (IMI-APPROACH)
Published in Research involvement and engagement (10-05-2021)“…APPROACH is an EU-wide research consortium with the goal to identify different subgroups of knee osteoarthritis to enable future differential diagnosis and…”
Get full text
Journal Article -
9
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum
Published in Molecular and cellular neuroscience (01-10-2008)“…Neuropeptide Y (NPY) gene transduction of the brain using viral vectors in epileptogenic regions can effectively suppress seizures in animals, and is being…”
Get full text
Journal Article -
10
Correction to: Making the patient voice heard in a research consortium: experiences from an EU project (IMI-APPROACH)
Published in Research involvement and engagement (19-04-2022)Get full text
Journal Article -
11
Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study
Published in Alzheimer's research & therapy (23-04-2021)“…Functional decline in Alzheimer's disease (AD) is typically measured using single-time point subjective rating scales, which rely on direct observation or…”
Get full text
Journal Article -
12
Editorial
Published in European journal of pharmaceutics and biopharmaceutics (01-06-2010)Get full text
Journal Article -
13
Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia
Published in European cytokine network (01-03-2017)“…Endotoxemia induces pronounced changes in leukocyte count and enhances the release of many cytokines. However, the molecular regulation of this cytokine…”
Get full text
Journal Article -
14
VEGF Receptor-2
Published in PloS one (12-07-2012)“…Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and…”
Get full text
Journal Article -
15
Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia
Published in Critical care medicine (01-05-2004)“…OBJECTIVE:Clinical trials show that interleukin (IL)-6 represents a predictive marker in human sepsis. Furthermore, IL-6 has been proposed as a candidate…”
Get full text
Journal Article -
16
Galanin expressed in the excitatory fibers attenuates synaptic strength and generalized seizures in the piriform cortex of mice
Published in Experimental neurology (01-08-2006)“…The neuropeptide galanin is considered to be an endogenous antiepileptic agent, presumably acting via inhibition of glutamate release. Previously, we have…”
Get full text
Journal Article -
17
Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity
Published in Neuroscience (19-12-2007)“…Abstract Gene therapy–based overexpression of endogenous seizure-suppressing molecules represents a promising treatment strategy for epilepsy. Viral…”
Get full text
Journal Article -
18
VASCULAR ENDOTHELIAL GROWTH FACTOR SUPPRESSES EPILEPTIC ACTIVITY IN MICE
Published in 28th International Epilepsy Congress, 2009,Budapest, Hungary,2009-06-28 - 2009-07-02 (2009)Get full text
Conference Proceeding -
19
Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level
Published in Clinical immunology (Orlando, Fla.) (01-03-2005)“…Interleukin 6 (IL-6) performs a prominent role during sepsis. To examine the molecular regulation of IL-6, IL-6 receptor, and signaling receptor gp130 during…”
Get full text
Journal Article